More Plates More Dates Bryan Johnson's $25,000 Follistatin Gene Therapy - Dissecting The Results
Jan 1, 2025
Bryan Johnson, an entrepreneur and investor renowned for his biohacking pursuits, discusses his innovative experiments with follistatin gene therapy. He reveals insights on its potential for muscle growth and critiques its effectiveness versus social media hype. Johnson reviews a recent study examining stable health markers and highlights the complexities of isolating therapy effects. The conversation also confronts exaggerated claims about biological age reduction, emphasizing the need for rigorous research and a consensus in the medical community.
AI Snips
Chapters
Transcript
Episode notes
Follistatin Gene Therapy Results
- Bryan Johnson's follistatin levels increased by 160% two weeks after follistatin gene therapy.
- This therapy doesn't edit genes but increases follistatin production.
Follistatin Gene Therapy Mechanism
- The follistatin gene therapy doesn't modify DNA.
- It introduces a plasmid into the nucleus, increasing follistatin protein production.
Follistatin Hype vs. Reality
- Derek discusses the hype around follistatin in bodybuilding.
- He mentions a less impressive human clinical trial and questions the ROI of a $25,000 shot.